Resources
About Us
Home Report
Store
Smart Insulin Pens Market
Smart Insulin Pens Market Size, Share, Forecast, & Trends Analysis by Product (Reusable, Disposable Prefilled, Cartridge) Connectivity (Bluetooth, NFC) Compatibility (Blood Glucose Monitor, CGM) Channel (Hospital, Retail, Online) - Global Forecast to 2031
Report ID:MRHC - 1041300 Pages: 270 Aug-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Smart Insulin Pens Market is expected to reach $ 776.5 Million by 2031, at a CAGR of 11.2% from 2024 to 2031.
Smart Insulin Pens Market Size & Forecast
This market's growth is being driven by a spike in diabetes cases, a preference for digital health solutions, technological advancements in smart insulin pens, an increase in demand for drug self-administration, and diabetes awareness initiatives. The expensive cost of smart insulin pens, along with the availability of alternatives, may limit market expansion.
Furthermore, rising demand for remote monitoring and telemedicine, partnerships and collaborations among smart insulin pen manufacturers, expanding economies, and personalized diabetes management are expected to create market growth. However, a lack of understanding about the use of smart insulin pens in developing nations, as well as a preference for traditional insulin delivery techniques, pose substantial challenges to the market's growth.
Moreover, the integration with Continuous Glucose Monitoring (CGM) systems is a prominent trend in the smart insulin pens market.
Smart Insulin Pens Market Growth Drivers
Increasing Prevalence of Diabetes
Diabetes, a chronic condition caused by lack of physical activity, being overweight, heredity, and lack of insulin in the body, is a significant driver of the smart insulin pens market. The increasing prevalence of diabetes, as reported by the International Diabetes Federation (IDF) and the Centers for Disease Control and Prevention (CDC), is expected to significantly impact the market.
In addition, in 2021, 61 million people lived with Type 2 Diabetes (T2D) in Europe. (Source: International Diabetes Federation (IDF)). Diabetes requires regular management and monitoring of insulin levels. Smart insulin pens automatically record when a person injects insulin, identifying the amount injected and the time of day. Thus, the rising prevalence of diabetes is driving the growth of the smart insulin pens market.
Click here to: Get Free Sample Pages of this Report
Technological Advancements in Smart Insulin Pens
Technological advances in insulin delivery were restricted to insulin pump users, and traditional methods of insulin delivery, such as vials, syringes, and insulin pens, were unaffected by modern digital technologies. With the recent introduction of smart insulin pens, an increasingly wider population with diabetes is able to utilize a digital tool to simplify and improve insulin therapy.
Smart insulin pens offer several advantages over traditional insulin delivery systems, such as preventing skipping or missing scheduled doses, calculating each dose by utilizing the patient's current carbohydrate intake, blood glucose level, meal size, active insulin, and the parameters indicated by medical professionals, delivering diabetes data analysis to the doctor as required, and connecting with a smartphone and watch with established diabetes.
In addition, enhanced data tracking caps were approved and added to disposable insulin pens to track doses. For instance, in May 2021, Bigfoot Biomedical Inc. (U.S.) obtained FDA 510(k) clearance approval for the Bigfoot Unity diabetes management system, which includes linked smartpen caps for insulin pens used to treat type 1 and 2 diabetes. Such advances present an opportunity for the smart insulin pens market.
Smart Insulin Pens Market Opportunities
Growing Demand for Remote Monitoring and Telemedicine
The demand for remote monitoring and telemedicine has increased rapidly after the pandemic as they reduce hospital visits, facilitate virtual consultations, and prevent the spread of viral diseases. Further, they help transmit patient-related data to physicians from remote places. Smart insulin pens are coupled with telemedicine platforms, permitting patients to transmit insulin usage information to their doctors during virtual visits. This data interchange allows doctors to modify insulin dosages, make accurate treatment decisions, and deliver personalized suggestions remotely.
In addition, remote monitoring technologies enable doctors and nurses to observe and track their patients’ health data, such as blood glucose levels, insulin use, and other important indicators. Smart insulin pens communicate and record insulin dose data, providing real-time insights. Further, remote monitoring and telemedicine eliminate geographical challenges, making medical treatments more accessible, particularly among people who have limited mobility and live in distant places. Smart insulin pens enhance this ability by allowing people to easily share their insulin results with doctors from their own homes. This easily accessible feature accelerates the adoption of smart insulin pens, creating an opportunity to market.
Partnerships and Collaborations by the Smart Insulin Pens Companies
Various public-private organizations are focusing on partnerships and collaborations to assist people with diabetes management more easily and to enhance treatment outcomes. For instance:
-
In March 2023, Diabeloop SA (France) and Novo Nordisk A/S (Denmark) collaborated to integrate Novo Nordisk's NovoPen 6 and NovoPen Echo Plus, new-generation connected and reusable pens, with Diabeloop's DBL-4pen, a self-learning algorithm for Multiple Daily Injection (MDI) therapy. The integrated technology will be tested on people with Type 2 diabetes to assess its effectiveness and therapeutic benefits.
- In May 2021, F. Hoffmann-La Roche Ltd (Switzerland) and Eli Lilly and Company (U.S) cooperated to integrate Eli Lilly's Tempo Smart Button into the mySugr app. This integration allows users to manage insulin pen and diabetes-related data in one place.
- In May 2021, Eli Lilly and Company (U.S.) collaborated with Dexcom, Glooko, myDiabby Healthcare (France), and F. Hoffmann-La Roche Ltd (Switzerland) to offer linked insulin pen solutions for diabetics in the US.
Thus, increasing partnerships and collaborations between the companies create an opportunity for the smart insulin pens market.
Smart Insulin Pens Market Trends
Integration with Continuous Glucose Monitoring (CGM) Systems
Integration with Continuous Glucose Monitoring (CGM) permits smart insulin pens to connect real-time insulin or blood sugar levels of a diabetic patient instantly from the CGM sensor. This real-time data allows people to make more informed choices about insulin doses. By integrating glucose levels with insulin administration, patients can modify their insulin doses depending on their present glucose levels, thereby improving glycemic control.
Furthermore, various companies are launching CGM-integrated smart insulin pen. For instance, in September 2023, Medtronic plc (Ireland) received the CE (Conformité Européenne) Mark approval for Simplera, continuous glucose monitors integrated with InPen smart insulin pen, to offer personalized, real-time dosing guidance to simplify diabetes management.
Smart Insulin Pens Market Analysis: Key Findings
By Product: In 2024, the Insulin Cartridges Segment to Dominate the Smart Insulin Pens Market
Based on product, the smart insulin pens market is segmented into reusable insulin pens, disposable prefilled insulin pens, insulin cartridges, and accessories. In 2024, the insulin cartridges segment is expected to account for the largest share of 63.3% of the smart insulin pens market. This segment’s large market share is attributed to the increasing number of diabetes cases and benefits offered by insulin cartridges, such as providing greater comfort and ease of use than standard vials and syringes. Pre-filled cartridges are readily put into insulin pens, making insulin administration easier for people with diabetes.
Moreover, this segment is also expected to register the highest CAGR of 12.5% during the forecast period.
By Connectivity: In 2024, the Bluetooth Connectivity Segment to Dominate the Smart Insulin Pens Market
Based on connectivity, the smart insulin pens market is segmented into Bluetooth connectivity and Near Field Communication (NFC) connectivity. In 2024, the Bluetooth connectivity segment is expected to account for the larger share of the smart insulin pens market. This segment’s large market share can be attributed to the benefits offered by Bluetooth connectivity in smart insulin pens, such as the ability to connect and send information to mobile applications, the long range of connectivity, and the ability to provide insulin recommendations through the integration of CGM systems.
By Glucose Monitor Compatibility: the Blood Glucose Monitors (BGMs) Compatible Pens Segment to Dominate the Smart Insulin Pens Market
Based on glucose monitor compatibility, the smart insulin pens market is segmented into Blood Glucose Monitors (BGMs) compatible pens and Continuous Glucose Monitors (CGMs) compatible pens. In 2024, the Blood Glucose Monitors (BGMs) compatible pens segment is expected to account for the larger share of the smart insulin pens market. This segment's substantial share of the market is due to the benefits that BGMs provide over CGMs, such as lower cost, no need to connect equipment to the body, and no need to implant sensors into the user's skin.
By Purchase Channel: the Retail Pharmacies to Dominate the Smart Insulin Pens Market
Based on purchase channel, the smart insulin pens market is segmented into hospital pharmacies, retail pharmacies, and online/E-commerce platforms. In 2024, the retail pharmacies segment is expected to account for the largest share of 49.2% of the smart insulin pens market. This segment’s large market share is attributed to the availability of retail pharmacies in nearby areas and the opportunity for customers to inspect the product before making a purchase.
Geographical Analysis
In 2024, North America is expected to account for the largest share of 35% of the smart insulin pens market, followed by Europe and Asia-Pacific. North America’s significant market share can be attributed to several key factors, including the presence of major smart insulin pens companies such as Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), and Medtronic plc (Ireland), increasing healthcare expenditure, rising demand for self-administration of drugs, technological advancements in smart insulin pens, and rising number of diabetes cases in this region are some of the major factors driving the growth of the region.
Moreover, the market in Asia-Pacific is expected to register the highest CAGR of 12.1% during the forecast period. The rise of this regional market can be ascribed to increased knowledge of smart insulin pens, diabetes awareness campaigns in countries such as China and India, and improved healthcare infrastructure.
Smart Insulin Pens Market: Key Companies
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted in the last three to four years. Some of the key players operating in the smart insulin pens market are Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Medtronic plc (Ireland), Emperra GmbH E-Health Technologies (Germany), pendiq GmbH (Germany), Jiangsu Delfu medical device Co., Ltd (China), Tandem Diabetes Care, Inc. (U.S.), Ypsomed AG (Switzerland), and Bigfoot Biomedical, Inc. (U.S.).
Smart Insulin Pens Industry Overview: Latest Developments from Key Industry Players
-
In February 2023, Innovation Zed Ltd. (Ireland) received CE mark clearance in Europe for its InsulCheck Dose insulin pen, which provides real-time injection event data to a matching display device.
-
In December 2022, BIOCORP (France) received FDA 510(K) authorization to market Mallya, a smart medical device that connects insulin pens.
- In November 2022, Eli Lilly and Company (U.S.) launched Tempo, a personalized diabetes management platform consisting of three components: Tempo Smart Button, TempoSmart app, and Tempo Pen prefilled insulin pen. This platform provides personalized guidance for adults with diabetes.
Smart Insulin Pens Market: Research Summary
|
Particulars |
Details |
|
Number of Pages |
270 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2023 |
|
CAGR (Value) |
11.2% |
|
Market Size (Value) |
USD 776.5 Million by 2031 |
|
Segments Covered |
By Product
By Connectivity
By Glucose Monitor Compatibility
By Purchase Channel
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Austria, Netherlands, Rest of Europe) Asia–Pacific (Japan, China, India, South Korea, Australia, Rest of Asia–Pacific), Latin America, and Middle East & Africa |
|
Key Companies |
Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Medtronic plc (Ireland), Emperra GmbH E-Health Technologies (Germany), pendiq GmbH (Germany), Jiangsu Delfu medical device Co., Ltd (China), Tandem Diabetes Care, Inc. (U.S.), Ypsomed AG (Switzerland), and Bigfoot Biomedical, Inc. (U.S.), |
Key questions answered in the smart insulin pens market report:
This study offers a detailed assessment of the smart insulin pens market sizes & forecasts based on product, connectivity, glucose monitor compatibility, and purchase channel. This report also involves the value analysis of various segments and subsegments of the smart insulin pens market at the regional and country levels.
The smart insulin pens market is expected to reach 776.5 million by 2031, at a CAGR of 11.2% during the forecast period.
Among the products covered in this report, in 2024, the insulin cartridges segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the increasing number of diabetes cases and benefits offered by insulin cartridges, such as providing greater comfort and simplicity of use than standard vials and syringes. Pre-filled cartridges are readily put into insulin pens, making insulin administration easier for people with diabetes.
Among the connectivity covered in this report, in 2024, the Bluetooth connectivity segment is expected to account for the largest share of the smart insulin pens market. The large market share of this segment can be attributed to the benefits offered by Bluetooth connectivity in smart insulin pens, such as the ability to connect and send information to mobile applications and the long range of connectivity, contributing to the significant market share of this segment.
The growth of this market is driven by the increasing number of diabetes cases, the increasing preference for digital health solutions, technological advancements in smart insulin pens, the increasing demand for drug self-administration, and increasing diabetes awareness programs.
Moreover, growing demand for remote monitoring and telemedicine, partnerships and collaborations by smart insulin pens companies, emerging economies, and personalized diabetes management are expected to create market growth opportunities.
The key players profiled in the smart insulin pens market report are Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Medtronic plc (Ireland), Emperra GmbH E-Health Technologies (Germany), pendiq GmbH (Germany), Jiangsu Delfu medical device Co., Ltd (China), Tandem Diabetes Care, Inc. (U.S.), Ypsomed AG (Switzerland), and Bigfoot Biomedical, Inc. (U.S.).
Emerging economies, such as China and India, are expected to provide significant growth opportunities for market players due to the growing awareness of diabetes, increasing demand for self-administration of drugs, and increasing number of diabetes cases in these countries.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Number of Diabetes Cases
4.2.2. Increasing Preference for Digital Health Solutions
4.2.3. Technological Advancements in Smart Insulin Pens
4.2.4. Increasing Demand for Self-Administration of Drugs
4.2.5. Increasing Diabetes Awareness Programs
4.3. Restraints
4.3.1. High Cost of Smart Insulin Pens
4.3.2. Availability of Alternatives to Smart Insulin Pens
4.4. Opportunities
4.4.1. Growing Demand for Remote Monitoring and Telemedicine
4.4.2. Partnerships and Collaborations by the Smart Insulin Pens Companies
4.4.3. Emerging Economies
4.4.4. Personalized Diabetes Management Program
4.5. Challenges
4.5.1. Lack of Awareness Regarding the Use of Smart Insulin Pens in Developing Countries
4.5.2. Preference for Traditional Insulin Delivery Methods
4.6. Trends
4.6.1. Integration with Continuous Glucose Monitoring (CGM) Systems
4.7. Factor Analysis
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Parent/Adjacent Market Analysis
4.11. Porter’s Five Forces Analysis
5. Smart Insulin Pens Market Assessment—by Product
5.1. Overview
5.2. Reusable Insulin Pens
5.3. Disposable Prefilled Insulin Pens
5.4. Insulin Cartridges
5.5. Accessories
6. Smart Insulin Pens Market Assessment—by Connectivity
6.1. Overview
6.2. Bluetooth Connectivity
6.3. Near Field Communication (NFC) Connectivity
7. Smart Insulin Pens Market Assessment—by Glucose Monitor Compatibility
7.1. Overview
7.2. Blood Glucose Monitors (BGMs) Compatible Pens
7.3. Continuous Glucose Monitors (CGMs) Compatible Pens
8. Smart Insulin Pens Market Assessment—by Purchase Channel
8.1. Overview
8.2. Hospital Pharmacies
8.3. Retail Pharmacies
8.4. Online/E-commerce Platforms
9. Smart Insulin Pens Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Austria
9.3.7. Netherlands
9.3.8. Rest of Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Australia
9.4.7. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis/Market Rankings of Key Players (2023)
11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
11.1. Novo Nordisk A/S
11.2. Eli Lilly and Company
11.3. Sanofi S.A.
11.4. Medtronic plc
11.5. Emperra GmbH E-Health Technologies
11.6. pendiq GmbH
11.7. Jiangsu Delfu medical device Co., Ltd
11.8. Tandem Diabetes Care, Inc.
11.9. Ypsomed AG
11.10. Bigfoot Biomedical, Inc.
(Note: SWOT analysis of the top 5 companies will be provided.)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Global Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 2 Global Reusable Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Disposable Prefilled Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Smart Insulin Pens Cartridges Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Smart Insulin Pens Accessories, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 7 Global Bluetooth Connected Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Near Field Communication (NFC) Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 10 Global Blood Glucose Monitors (BGMs) Compatible Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Continuous Glucose Monitors (CGMs) Compatible Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 13 Global Smart Insulin Pens Market for Hospital Pharmacies, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Smart Insulin Pens Market for Retail Pharmacies, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Smart Insulin Pens Market for Online/E-commerce Platforms, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 17 North America: Smart Insulin Pens Market, by Country, 2022–2031 (USD Million)
Table 18 North America: Smart Insulin Pens Market, by product, 2022–2031 (USD Million)
Table 19 North America: Smart Insulin Pens Market, by connectivity, 2022–2031 (USD Million)
Table 20 North America: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 21 North America: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 22 U.S.: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 23 U.S.: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 24 U.S.: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 25 U.S.: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 26 Canada: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 27 Canada: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 28 Canada: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 29 Canada: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 30 Europe: Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 31 Europe: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 32 Europe: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 33 Europe: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 34 Europe: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 35 Germany: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 36 Germany: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 37 Germany: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 38 Germany: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 39 France: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 40 France: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 41 France: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 42 France: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 43 U.K.: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 44 U.K.: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 45 U.K.: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 46 U.K.: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 47 Italy: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 48 Italy: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 49 Italy: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 50 Italy: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 51 Spain: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 52 Spain: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 53 Spain: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 54 Spain: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 55 Austria: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 56 Austria: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 57 Austria: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 58 Austria: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 59 Netherlands: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 60 Netherlands: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 61 Netherlands: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 62 Netherlands: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 63 Rest of Europe: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 64 Rest of Europe: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 65 Rest of Europe: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 66 Rest of Europe: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 67 Asia-Pacific: Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 68 Asia-Pacific: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 69 Asia-Pacific: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 70 Asia-Pacific: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 71 Asia-Pacific: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 72 Japan: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 73 Japan: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 74 Japan: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 75 Japan: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 76 China: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 77 China: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 78 China: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 79 China: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 80 India: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 81 India: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 82 India: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 83 India: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 84 South Korea: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 85 South Korea: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 86 South Korea: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 87 South Korea: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 88 Australia: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 89 Australia: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 90 Australia: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 91 Australia: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 92 Rest of Asia-Pacific: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 93 Rest of Asia-Pacific: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 94 Rest of Asia-Pacific: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 95 Rest of Asia-Pacific: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 96 Latin America: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 97 Latin America: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 98 Latin America: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 99 Latin America: Smart Insulin Pens Market, by Purchase Channel, 2022–2031 (USD Million)
Table 100 Middle East & Africa: Smart Insulin Pens Market, by Product, 2022–2031 (USD Million)
Table 101 Middle East & Africa: Smart Insulin Pens Market, by Connectivity, 2022–2031 (USD Million)
Table 102 Middle East & Africa: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022–2031 (USD Million)
Table 103 Middle East & Africa: Smart Insulin Pens Market, by purchase Channel, 2022–2031 (USD Million)
Table 104 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Smart Insulin Pens Market, by Product, 2024 VS. 2031 (USD Million)
Figure 8 Global Smart Insulin Pens Market, by Connectivity, 2024 VS. 2031 (USD Million)
Figure 9 Global Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2024 VS. 2031 (USD Million)
Figure 10 Global Smart Insulin Pens Market, by Purchase Channel, 2024 VS. 2031 (USD Million)
Figure 11 Global Smart Insulin Pens Market, by Geography
Figure 12 Impact Analysis: Smart Insulin Pens Market
Figure 13 Global Smart Insulin Pens Market, by Product, 2024 VS. 2031 (USD Million)
Figure 14 Global Smart Insulin Pens Market, by Connectivity, 2024 VS. 2031 (USD Million)
Figure 15 Global Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2024 VS. 2031 (USD Million)
Figure 16 Global Smart Insulin Pens Market, by Purchase Channel, 2024 VS. 2031 (USD Million)
Figure 17 Global Smart Insulin Pens Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 18 North America: Smart Insulin Pens Market Snapshot
Figure 19 Europe: Smart Insulin Pens Market Snapshot
Figure 20 Asia-Pacific: Smart Insulin Pens Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 22 Global Smart Insulin Pens Market: Competitive Benchmarking, by Product
Figure 23 Global Smart Insulin Pens Market: Competitive Benchmarking, by Geography
Figure 24 Global Smart Insulin Pens Market: Competitive Dashboard
Figure 25 Global Smart Insulin Pens Market: Market Share Analysis/Market Ranking, By Key Players, 2023
Figure 26 Novo Nordisk A/S: Financial Overview (2023)
Figure 27 Eli Lilly and Company: Financial Overview (2023)
Figure 28 Sanofi S.A.: Financial Overview (2023)
Figure 29 Medtronic plc: Financial Overview (2023)
Figure 30 Emperra GmbH E-Health Technologies: Financial Overview (2023)
Figure 31 Tandem Diabetes Care, Inc.: Financial Overview (2023)
Figure 32 Ypsomed AG (Switzerland): Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Insulin Pens Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: May-2024
Digital Diabetes Market - Global Opportunity Analysis and Industry Forecast (2018 - 2025)
Published Date: Feb-2019
Wearable Medical Devices Market - Global Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Aug-2024
Pen Needles Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Aug-2024
